Companies

See how salaries can vary from company to company

Tribune Publishing Company, a media company, publishes newspapers worldwide. The company operates in two segments, M and X. It publishes daily newspapers; weekly newspapers; and digital platforms, such as Websites and mobile applications. The company also provides various digital marketing services, which include the development of mobile Websites, search engine marketing and optimization, social media account management, and content marketing for its customers' Web presence for small to medium size businesses. In addition, it offers TCA, a syndication and licensing business that provides dail... view company details

Paragon Technology Group, Inc. is a fast-growing information technology company providing professional services to the public sector. Founded in 1997, Paragon has been recognized as one of the top 50 fastest growing companies in the Washington, D.C., Metro area and one of the top small businesses in the US. Paragon delivers an extensive suite of services, including IT systems engineering and application development, governance and PMO implementation and support, business intelligence and data management, enterprise modernization, and financial and quality management, across the public sector. ... view company details

Thor Equities is a leader in urban real estate development, leasing and management, pursuing premier retail and mixed-use assets in high-density areas. Thor Equities provides the best possible "High Street" retail and mixed-use building environments throughout the urban landscape across the United States, Latin America and Europe - all while delivering attractive, risk-adjusted returns to investors. The Thor Equities team delivers optimum results - assessing the most efficient way to operate a property to generate returns for investors by recognizing potential, reducing operating expenses, inc... view company details

An entrepreneurial and spirited hospitality company, Twenty Four Seven Hotels delivers highly specialized services in hotel management, investment and development. After a decade of focusing on upscale select-service hotels, Twenty Four Seven Hotels firmly established itself in the growing lifestyle hotel market segment with the 2016 opening of the first Moxy hotel in the United States. Headquartered in Newport Beach, California, our growing portfolio surpassed 25 hotels in 2017, comprised of 3,500 rooms. Concentrated in the Western U.S. markets we have several new developments under way in ou... view company details

As of December 31, 2017, UPD Holding Corp. was acquired by Record STREET Brewing Company, in a reverse merger transaction. UPD Holding Corp. focuses on providing blend meal replacements, dietary specialty foods, and nutraceuticals. It intends to offer Catalyst, which provides essential vitamins and plant compounds that are necessary to aid in metabolic functions; Mini-Meal that offers the essential whey protein isolate intake; Multi-Pro, which provides essential broad-spectrum vitamins and minerals; and BittX that is used to reform the body's disposition toward bitter foods. The company was fo... view company details

The United Nations (UN) is an intergovernmental organization that was tasked to maintain international peace and security, develop friendly relations among nations, achieve international co-operation and be a centre for harmonizing the actions of nations. The headquarters of the UN is in Manhattan, New York City, and is subject to extraterritoriality. Further main offices are situated in Geneva, Nairobi, and Vienna. The organization is financed by assessed and voluntary contributions from its member states. Its objectives include maintaining international peace and security, protecting human r... view company details

Similar to how boutique hotels eclipsed corporate brands as the new standard in the hotel industry, Urby sets the new standard for rental apartment living. We address this with hospitality, design and culture. Our employees express Urby culture through our core foundation: Urby Vibe We are passionate. We are optimistic. We are fun. We are genuine. Urby Mind We are curious. We are agile. We are innovative. We are unstoppable. Urby Heart We are kind. We are courageous. We are humble. We are grateful. Urby Team We are approachable. We are dedicated. We are collaborative. We are dependable. There ... view company details

Vectrus, Inc. provides facility and logistics, and information technology and network communication services to the U.S. government worldwide. The company offers facility and logistics services, such as airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, warehouse management and distribution, and equipment maintenance, repair, and services for U.S. Army, Air Force, Navy, and Marines. It also provides information technology and network communication services, including sust... view company details

Foamix Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for dermatological therapy in the United States, France, Denmark, and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline that has completed third pivotal Phase III clinical trial for the treatment of moderate-to-severe acne; and FMX103, which is in Phase III clinical trial for the treatment of moderate-to-severe papulopustular rosacea. The company's product pipeline includes FCD105 and FMX109 fo... view company details

Volunteers of America is the charity that always steps forward to help the most vulnerable. Since 1896 Volunteers of America has taken on the most difficult tasks to help the most underserved. Volunteers of America Northern New England touches the lives of more than 6,000 people in Maine, New Hampshire and Vermont. With nearly 30 programs we provide basic human necessities such as shelter and food or life-renewing assistance such as life skills training, rehabilitation, counseling, wrap-around support services, case management services, community mediation, connection to community resources, a... view company details

W&T Offshore, Inc., an independent oil and natural gas producer, engages in the acquisition, exploration, and development of oil and natural gas properties in the Gulf of Mexico. The company sells crude oil, natural gas liquids, and natural gas. It holds working interests in approximately 48 offshore fields in federal and state waters. The company also owns interests in approximately 123 offshore structures. It has interests in offshore leases covering approximately 390,000 net acres spanning across the Outer Continental Shelf off the coasts of Louisiana, Texas, Mississippi, and Alabama. As of... view company details

Whiteboard Marketing LLC is a full-service sales and marketing consulting firm that provides a strategic partnership alliance with each client we serve. Our services include strategic marketing planning; marketing research internet/inbound marketing; social media campaigns; email strategy; SEO, PPC and SEM programs; media buying and placement; video production, website design, hosting and management; print collateral production and other services that drive sales and brand awareness. At Whiteboard Marketing, we utilize a calculated integration of all of these marketing initiatives to achieve R... view company details

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of various small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing. The company's lead product candidates for the treatment of CF include PTI-801, a third generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector agent; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. It has collaboration agreements with Cystic Fibrosis Foundation, Inc. to research, develop, and commercialize produc... view company details

Our Growth and Our Commitment Continues... "Since its founding in 1970, Youth and Family Alternatives, Inc. ("YFA") has helped more than 175,000 children and families in the Tampa Bay & Central Florida area. In the early years, YFA served as a "drop-in" center. Young people could participate in everything from games or discussion groups to individual counseling with a trained volunteer. We Currently Offer: Substance Abuse Prevention and Intervention Services Foster Care and Adoption Service Runaway/Youth Crisis Services Family Counseling Our Goal: Encourage positive growth and development of y... view company details

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase III clinical trials for the treatment of rituximab-refractory epstein-barr virus (EBV) associated post-transplant lymphoproliferative disorder, as well as other EBV associated hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies an... view company details

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead Characterized Oral Desensitization ImmunoTherapy (CODIT) product candidate is AR101, an investigational biologic, which is in Phase III clinical trial for the treatment of patients with peanut allergy. The company also engages in the research and development of AR201, a CODIT product candidate for the treatment of egg allergy in pediatric and young adult patients; and other CODIT product candidates targeting food a... view company details

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in early clinical development stage for the treatment of Arginase 1 deficiency, an autosomal recessive metabolic disease caused by a marked decrease in the activity of the native arginase 1 enzyme; and for treating Arginine dependent cancers. Its preclinical pipeline products comprise AEB4104, a recombi... view company details

Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. The company is developing AT132, which is in Phase I/II clinical studies for the treatment of X-linked myotubular myopathy (XLMTM); AT342 that is in Phase I/II clinical studies to treat crigler-najjar syndrome; AT845, which is in preclinical studies for the treatment of pompe disease; and AT307 to treat CASQ2 subtype of catecholaminergic polymorphic ventricular tachyca... view company details

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's pipeline include ARO-AAT, a RNA interference (RNAi) therapeutic candidate for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3 to treat hypertriglyceridemia; ARO-ANG3 to reduce production of angiopoietin-like protein 3; ARO-ENaC to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; and ARO-HIF2 for the treatment of clear cell renal cell carcinoma. It is also involved in the development... view company details

Advaxis, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of Listeria monocytogenes (Lm) technology based antigen delivery product in the United States. It is developing therapies for HPV-related cancers using axalimogene filolisbac (AXAL) for the treatment of head and neck cancer. The company is also developing ADXS-PSA for the treatment of prostate cancer; and ADXS-NEO, an individualized Lm technology antigen delivery product candidate that is designed to create individualized therapies by activating the patient's immune system to respond... view company details